- Home
- THH vs FENC Comparison
THH vs FENC Comparison
Compare THH & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THH
- FENC
- Stock Information
- Founded
- THH 2013
- FENC 1996
- Country
- THH Japan
- FENC United States
- Employees
- THH N/A
- FENC N/A
- Industry
- THH
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- THH
- FENC Health Care
- Exchange
- THH Nasdaq
- FENC Nasdaq
- Market Cap
- THH 270.5M
- FENC 225.4M
- IPO Year
- THH 2025
- FENC 2001
- Fundamental
- Price
- THH $4.56
- FENC $9.18
- Analyst Decision
- THH
- FENC Strong Buy
- Analyst Count
- THH 0
- FENC 2
- Target Price
- THH N/A
- FENC $13.50
- AVG Volume (30 Days)
- THH 715.5K
- FENC 66.4K
- Earning Date
- THH 01-01-0001
- FENC 08-14-2025
- Dividend Yield
- THH N/A
- FENC N/A
- EPS Growth
- THH N/A
- FENC N/A
- EPS
- THH 0.02
- FENC N/A
- Revenue
- THH $20,390,561.00
- FENC $33,302,000.00
- Revenue This Year
- THH N/A
- FENC $0.96
- Revenue Next Year
- THH N/A
- FENC $51.71
- P/E Ratio
- THH $292.44
- FENC N/A
- Revenue Growth
- THH 14.93
- FENC N/A
- 52 Week Low
- THH $4.24
- FENC $3.96
- 52 Week High
- THH $12.00
- FENC $9.42
- Technical
- Relative Strength Index (RSI)
- THH N/A
- FENC 61.39
- Support Level
- THH N/A
- FENC $8.73
- Resistance Level
- THH N/A
- FENC $9.07
- Average True Range (ATR)
- THH 0.00
- FENC 0.34
- MACD
- THH 0.00
- FENC 0.07
- Stochastic Oscillator
- THH 0.00
- FENC 100.00
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.